Bioventus (BVS)
(Delayed Data from NSDQ)
$5.72 USD
+0.32 (5.93%)
Updated May 13, 2024 04:00 PM ET
After-Market: $5.71 -0.01 (-0.17%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | 0.07 |
EPS Last Quarter | 0.07 |
Last EPS Surprise | 240.00% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.27 |
Next Year | 0.43 |
EPS (TTM) | 0.33 |
P/E (F1) | 20.00 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 137.70M | 131.42M | 543.27M | 564.56M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 137.70M | 131.42M | 543.27M | 564.56M |
Low Estimate | 137.70M | 131.42M | 543.27M | 564.56M |
Year ago Sales | 137.07M | 120.79M | 512.34M | 543.27M |
Year over Year Growth Est. | 0.46% | 8.80% | 6.04% | 3.92% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.07 | 0.06 | 0.27 | 0.43 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.07 | 0.06 | 0.27 | 0.43 |
Low Estimate | 0.07 | 0.06 | 0.27 | 0.43 |
Year ago EPS | 0.14 | 0.05 | 0.02 | 0.27 |
Year over Year Growth Est. | -50.00% | 20.00% | 1,250.00% | 59.26% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.07 | 0.06 | 0.27 | 0.43 |
7 Days Ago | 0.07 | 0.06 | 0.16 | 0.40 |
30 Days Ago | 0.07 | 0.06 | 0.16 | 0.40 |
60 Days Ago | 0.15 | 0.11 | 0.38 | 0.51 |
90 Days Ago | 0.15 | 0.11 | 0.38 | 0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.07 | 0.06 | 0.27 | 0.43 |
Zacks Consensus Estimate | 0.07 | 0.06 | 0.27 | 0.43 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.07 | 0.07 | 0.05 | 0.14 | NA |
Estimate | -0.05 | 0.06 | 0.06 | 0.03 | NA |
Difference | 0.12 | 0.01 | -0.01 | 0.11 | 0.06 |
Surprise | 240.00% | 16.67% | -16.67% | 366.67% | 151.67% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more